KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 63 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $686,000 | -30.4% | 49,232 | -11.8% | 0.00% | -33.3% |
| Q4 2020 | $986,000 | -76.6% | 55,826 | -79.7% | 0.00% | -80.0% |
| Q3 2020 | $4,220,000 | +132.5% | 275,444 | +286.7% | 0.02% | +66.7% |
| Q2 2020 | $1,815,000 | +523.7% | 71,225 | +279.1% | 0.01% | +350.0% |
| Q1 2020 | $291,000 | +44.8% | 18,789 | +3.2% | 0.00% | +100.0% |
| Q4 2019 | $201,000 | -41.4% | 18,211 | +35.5% | 0.00% | 0.0% |
| Q3 2018 | $343,000 | – | 13,442 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Spearhead Capital Advisors, LLC | 202,580 | $2,601,000 | 2.82% |
| Lion Point Capital, LP | 480,000 | $5,140,000 | 1.13% |
| HHLR ADVISORS, LTD. | 2,920,023 | $37,493,000 | 0.99% |
| TANG CAPITAL MANAGEMENT LLC | 600,000 | $7,704,000 | 0.94% |
| Rubric Capital Management LP | 1,446,107 | $18,568,000 | 0.94% |
| AlphaCentric Advisors LLC | 43,000 | $552,000 | 0.57% |
| RICE HALL JAMES & ASSOCIATES, LLC | 749,933 | $9,629,000 | 0.56% |
| Parkman Healthcare Partners LLC | 126,192 | $1,620,000 | 0.46% |
| Birchview Capital, LP | 30,000 | $385,000 | 0.27% |
| Baker Brothers Advisors | 2,799,577 | $35,947,000 | 0.24% |